Concord Wealth Partners Bria Cell Therapeutics Corp. Transaction History

Concord Wealth Partners

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 07, 2023	SELL	$5.72 - $7.58 $14,300 - $18,950	-2,500 Reduced 14.06%	15,275 $98,000
Q2 2022 Aug 04, 2022	BUY	$4.28 - $11.9 $4,280 - $11,900	1,000 Added 5.96%	17,775 $103,000
Q1 2022 Apr 20, 2022	BUY	$5.91 - $10.14 $23,640 - $40,560	4,000 Added 31.31%	16,775 $170,000
Q4 2021 Jan 21, 2022	BUY	$7.1 - $10.61 $90,702 - $135,542	12,775 New	12,775 $106,000

Ticker BCTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,518,000
Market Cap $14.9M
Description
BriaCell Therapeutics Corp., an immuno-oncology biotechnology company, engages in developing immunotherapies for the treatment of cancer. Its lead candidate is Bria-IMT that is in Phase I/IIa clinical trial in a combination study with immune checkpoint inhibitors for the treatment of breast cancer. The company also has a cooperative research and...

Get notified when there are updates to the investment portfolio of Concord Wealth Partners, based on Form 13F filings with the SEC.

Stay updated on Concord Wealth Partners with notifications on news.